CAS 1030769-75-5

SRI 37892

CAS: 1030769-75-5

SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability.

Fórmula: C₂₆H₁₉N₅O₂S

Pureza: 99.93%

Cor e Forma: Solid

Peso molecular: 465.53

Ref: TM-T9662

SRI 37892

CAS: 1030769-75-5

SRI 37892

Pureza: ≥98%

Peso molecular: 465.53g/mol

Ref: 54-BUP07634

4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide

Produto Controlado

CAS: 1030769-75-5

4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide (AQBT) is a potent and selective inhibitor of ion channels. AQBT has a high affinity for Na+ currents in the CNS and peripheral nervous system of rats. It is a potent blocker of α7 nicotinic acetylcholine receptors. This compound also inhibits the activity of the neuronal γ amino butyric acid type A receptor (GABAAR).

Fórmula: C₂₆H₁₉N₅O₂S

Pureza: Min. 95%

Peso molecular: 465.5 g/mol

Ref: 3D-FRB76975